Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen J Forman

Showing results (111-120 of 500) with videos related to

Pageof 50
Sort By:
Leukemia & Lymphoma|August 10, 2011
A phase 2 study of vorinostat for treatment of relapsed or refractory Hodgkin lymphoma: Southwest Oncology Group Study S0517Mark H Kirschbaum, Bryan H Goldman, Jasmine M Zain, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 27, 2005
Amplification of RNAi--targeting HLA mRNAsSergio Gonzalez, Daniela Castanotto, Haitang Li, et al.
Human Immunology|September 4, 2012
KIR2DS2 and KIR2DS4 promoter hypomethylation patterns in patients undergoing hematopoietic cell transplantation (HCT)Ghislaine M Gallez-Hawkins, Xiuli Li, Anne E Franck, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 30, 2009
Improved outcomes using tacrolimus/sirolimus for graft-versus-host disease prophylaxis with a reduced-intensity conditioning regimen for allogeneic hematopoietic cell transplant as treatment of myelofibrosisDavid S Snyder, Joycelynne Palmer, Karl Gaal, et al.
Plos One|May 3, 2014
Cytokine induction of VCAM-1 but not IL13Rα2 on glioma cells: a tale of two antibodiesVaidehi Mahadev, Renate Starr, Sarah L Wright, et al.
Molecular Immunology|May 1, 2013
Chimeric γc cytokine receptors confer cytokine independent engraftment of human T lymphocytesMichelle R Hunter, Megan E Prosser, Vaidehi Mahadev, et al.
Plos One|November 9, 2013
Glioma IL13Rα2 is associated with mesenchymal signature gene expression and poor patient prognosisChristine E Brown, Charles D Warden, Renate Starr, et al.
Leukemia Research|July 8, 2014
Iron chelators induce autophagic cell death in multiple myeloma cellsVinod Pullarkat, Zhuo Meng, Cecile Donohue, et al.
JCI Insight|May 18, 2018
Glioblastoma-targeted CD4+ CAR T cells mediate superior antitumor activityDongrui Wang, Brenda Aguilar, Renate Starr, et al.
Cancer|November 8, 2017
Prevalence of anthracycline-related cardiac dysfunction in long-term survivors of adult-onset lymphomaSaro H Armenian, Luc Mertens, Cameron Slorach, et al.
Pageof 50

Showing results (111-120 of 500) with videos related to

Sort By:
Pageof 50
Leukemia & Lymphoma|August 10, 2011
A phase 2 study of vorinostat for treatment of relapsed or refractory Hodgkin lymphoma: Southwest Oncology Group Study S0517Mark H Kirschbaum, Bryan H Goldman, Jasmine M Zain, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 27, 2005
Amplification of RNAi--targeting HLA mRNAsSergio Gonzalez, Daniela Castanotto, Haitang Li, et al.
Human Immunology|September 4, 2012
KIR2DS2 and KIR2DS4 promoter hypomethylation patterns in patients undergoing hematopoietic cell transplantation (HCT)Ghislaine M Gallez-Hawkins, Xiuli Li, Anne E Franck, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 30, 2009
Improved outcomes using tacrolimus/sirolimus for graft-versus-host disease prophylaxis with a reduced-intensity conditioning regimen for allogeneic hematopoietic cell transplant as treatment of myelofibrosisDavid S Snyder, Joycelynne Palmer, Karl Gaal, et al.
Plos One|May 3, 2014
Cytokine induction of VCAM-1 but not IL13Rα2 on glioma cells: a tale of two antibodiesVaidehi Mahadev, Renate Starr, Sarah L Wright, et al.
Molecular Immunology|May 1, 2013
Chimeric γc cytokine receptors confer cytokine independent engraftment of human T lymphocytesMichelle R Hunter, Megan E Prosser, Vaidehi Mahadev, et al.
Plos One|November 9, 2013
Glioma IL13Rα2 is associated with mesenchymal signature gene expression and poor patient prognosisChristine E Brown, Charles D Warden, Renate Starr, et al.
Leukemia Research|July 8, 2014
Iron chelators induce autophagic cell death in multiple myeloma cellsVinod Pullarkat, Zhuo Meng, Cecile Donohue, et al.
JCI Insight|May 18, 2018
Glioblastoma-targeted CD4+ CAR T cells mediate superior antitumor activityDongrui Wang, Brenda Aguilar, Renate Starr, et al.
Cancer|November 8, 2017
Prevalence of anthracycline-related cardiac dysfunction in long-term survivors of adult-onset lymphomaSaro H Armenian, Luc Mertens, Cameron Slorach, et al.
Pageof 50